| 1 |
34093893 | The Outcome and Safety of Re-challenge Lutetium-177 PSMA (177Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer-a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report. | 2021 Jun |
1 |
| 2 |
32806261 | Anti-PSMA monoclonal antibody increases the toxicity of paclitaxel carried by carbon nanotubes. | 2020 Nov |
6 |
| 3 |
31248772 | Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates. | 2019 Aug 15 |
3 |
| 4 |
29608845 | Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate. | 2018 May 7 |
5 |
| 5 |
30151731 | PSMA Antibody-Conjugated Pentablock Copolymer Nanomicellar Formulation for Targeted Delivery to Prostate Cancer. | 2018 Nov |
2 |
| 6 |
27066372 | DUP1 peptide modified micelle efficiently targeted delivery paclitaxel and enhance mitochondrial apoptosis on PSMA-negative prostate cancer cells. | 2016 |
2 |
| 7 |
25419788 | PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking. | 2015 Jan 14 |
2 |
| 8 |
22915856 | Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner. | 2012 |
3 |
| 9 |
20707381 | Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. | 2010 Sep 28 |
1 |